Hakim Larbi Bouterfa founded OctreoPharm Sciences GmbH.

He is Chief Medical Officer of Eckert & Ziegler Strahlen- und Medizintechnik AG, Co-Managing Director at PentixaPharm GmbH (a subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG) and Managing Partner at 1717 Life Sciences Ventures GmbH.

In the past he held the position of Managing Director & VP-European Operations at Molecular Insight Pharmaceuticals GmbH and Medical Director-Sandostatin Franchise at Novartis Pharma GmbH.